Cross-fund · 5 holders
DNLI
DENALI THERAPEUTICS INC
CUSIP 24823R105
5
Tracked holders
$497.9M
Aggregate value
27,761,491
Shares
5
Active funds
Funds holding DNLI
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $250.3M | — | +319,233 | +2.5% |
| Vanguard | Institutional | Q4 2025 | $215.6M | — | +1,064,972 | +8.9% |
| Millennium | Multi-Strategy | Q1 2026 | $24.4M | 0.01% | +903,183 | +244.3% |
| Citadel | Multi-Strategy | Q1 2026 | $6.7M | — | -455,231 | -56.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $867,840 | — | -1,654,800 | -97.3% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.